Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients

NCT06514560 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT06514560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06514560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Observational
Overall status
Recruiting
Start date
June 18, 2024
Completion date
December 30, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniases